Transcriptomic heterogeneity of cultured ADSCs corresponds to embolic risk in the host
Summary: Stem cell therapy emerges as an effective approach for treating various currently untreatable diseases. However, fatal and unknown risks caused by their systemic use remain to be a major obstacle to clinical application. We developed a functional single-cell RNA sequencing (scRNA-seq) proce...
Main Authors: | Kaijing Yan, Jinlai Zhang, Wen Yin, Jeffrey N. Harding, Fei Ma, Di Wu, Haibo Deng, Pengfei Han, Rui Li, Hongxu Peng, Xin Song, Y. James Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258900422201094X |
Similar Items
-
Protocol to assess fatal embolism risks from human stem cells
by: Fei Ma, et al.
Published: (2023-06-01) -
Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis
by: Maria P. Mogavero, et al.
Published: (2024-04-01) -
The Oyster River Protocol: a multi-assembler and kmer approach for de novo transcriptome assembly
by: Matthew D. MacManes
Published: (2018-08-01) -
Venomix: a simple bioinformatic pipeline for identifying and characterizing toxin gene candidates from transcriptomic data
by: Jason Macrander, et al.
Published: (2018-07-01) -
Single Cell Transcriptomics to Understand HSC Heterogeneity and Its Evolution upon Aging
by: Léonard Hérault, et al.
Published: (2022-10-01)